178 related articles for article (PubMed ID: 8395651)
1. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.
Nordeen SK; Bona BJ; Moyer ML
Mol Endocrinol; 1993 Jun; 7(6):731-42. PubMed ID: 8395651
[TBL] [Abstract][Full Text] [Related]
2. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
Beck CA; Weigel NL; Moyer ML; Nordeen SK; Edwards DP
Proc Natl Acad Sci U S A; 1993 May; 90(10):4441-5. PubMed ID: 8389450
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation.
Kazmi SM; Visconti V; Plante RK; Ishaque A; Lau C
Endocrinology; 1993 Sep; 133(3):1230-8. PubMed ID: 8365365
[TBL] [Abstract][Full Text] [Related]
4. Synergistic enhancement of PRB-mediated RU486 and R5020 agonist activities through cyclic adenosine 3',5'-monophosphate represents a delayed primary response.
Kahmann S; Vassen L; Klein-Hitpass L
Mol Endocrinol; 1998 Feb; 12(2):278-89. PubMed ID: 9482668
[TBL] [Abstract][Full Text] [Related]
5. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Mymryk JS; Archer TK
Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
Chen A; Vaughan J; Vale WW
Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
[TBL] [Abstract][Full Text] [Related]
7. The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.
Zhang S; Jonklaas J; Danielsen M
Steroids; 2007 Jun; 72(6-7):600-8. PubMed ID: 17509631
[TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of apoptosis with glucocorticoids and 3',5'-cyclic adenosine monophosphate reveals agonist activity by RU 486.
Gruol DJ; Altschmied J
Mol Endocrinol; 1993 Jan; 7(1):104-13. PubMed ID: 8383286
[TBL] [Abstract][Full Text] [Related]
9. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
[TBL] [Abstract][Full Text] [Related]
10. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
Sartorius CA; Tung L; Takimoto GS; Horwitz KB
J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation.
Moyer ML; Borror KC; Bona BJ; DeFranco DB; Nordeen SK
J Biol Chem; 1993 Oct; 268(30):22933-40. PubMed ID: 7693681
[TBL] [Abstract][Full Text] [Related]
12. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway.
Turgeon JL; Waring DW
Mol Endocrinol; 1994 Jul; 8(7):860-9. PubMed ID: 7984148
[TBL] [Abstract][Full Text] [Related]
13. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
14. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
15. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148
[TBL] [Abstract][Full Text] [Related]
16. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
[TBL] [Abstract][Full Text] [Related]
17. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
18. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the role of ligand and thermal activation of specific DNA binding by in vitro synthesized human glucocorticoid receptor.
Burnstein KL; Jewell CM; Cidlowski JA
Mol Endocrinol; 1991 Jul; 5(7):1013-22. PubMed ID: 1944294
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptors take part in the apoptotic process of human lens epithelial cells, but the glucocorticoid receptor antagonist RU486 does not rescue the cells fully.
Wang L; Zhao W; Leng F; Ge J; Bu Z; Zhang Y; Liu P
Mol Biosyst; 2011 Jun; 7(6):1926-37. PubMed ID: 21451860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
